In renal cell carcinoma (RCC), METTL14 downregulates the expression of bromodomain PHD finger transcription factor (BPTF) to attenuate the oncogenic transcriptome, glycolytic reprogramming, and distal lung metastasis.387. Here, BPTF is linked to hereditary clear cell renal cell carcinoma.